A high density SNP genotyping approach within the 19q13 chromosome region identifies an association of a CNOT3 polymorphism with ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 71, Issue 5, 2012, Pages 714-717

  Díaz Peña, Roberto ^a   Aransay, Ana M ^b   Suárez Álvarez, Beatriz ^a   Bruges Armas, Jacome ^c   Rodríguez Ezpeleta, Naiara ^b   Regueiro, María ^b,d   Pimentel Santos, Fernando M ^e,f   Mulero, Juan ^g   Sánchez, Alejandra ^g   Collantes, Eduardo ^h   Queiro, Rubén ^a   Ballina, Javier ^a   Alves, Helena ⁱ   López Larrea, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b CIC BIOGUNE   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e NOVA MEDICAL SCHOOL   (Portugal)

^f HOSPITAL EGAS MONIZ   (Portugal)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ Ministerio da Saude Portuguese   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; CHROMOSOME 19Q; CNOT3 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; KIR3DL1 GENE; LAIR2 GENE; MAJOR CLINICAL STUDY; PORTUGAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; VALIDATION STUDY;

CHROMOSOMES, HUMAN, PAIR 19; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIGH-THROUGHPUT SCREENING ASSAYS; HLA-B27 ANTIGEN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; SPONDYLITIS, ANKYLOSING; TRANSCRIPTION FACTORS;

EID: 84859501672     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200661     Document Type: Article

References (19)

1. Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904-7.
2. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26. (Pubitemid 32289738)
3. Lee YH, Rho YH, Choi SJ, et al. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 2005;50:453-9. (Pubitemid 41483331)
4. The Australo-Anglo-American Spondyloarthritis Consortium (TASC). Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123-7.
5. Sims AM, Timms AE, Bruges-Armas J, et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008;67:1305-9.
6. Pointon JJ, Harvey D, Karaderi T, et al. The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD). Ann Rheum Dis 2010;69:1243-6.
7. Díaz-Peña R, Blanco-Gelaz MA, López-Larrea C. KIR genes and their role in spondyloarthropathies. Adv Exp Med Biol 2009;649:286-99.
8. Díaz-Peña R, Vidal-Castiñeira JR, Alonso-Arias R, et al. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum 2010;62:1000-6.
9. Díaz-Peña R, Blanco-Gelaz MA, Suárez-Alvarez B, et al. Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol 2008;69:437-42.
10. Kollnberger S, Bird L, Sun MY, et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002;46:2972-82. (Pubitemid 35315891)
11. Van de Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
12. International HapMap Consortium: A haplotype map of the human genome. Nature 2005;437:1299-320.
13. Oliphant A, Barker DL, Stuelpnagel JR, et al. BeadArray technology: enabling and accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002;Suppl:56-8, 60-1.
14. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75. (Pubitemid 47330214)
15. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
16. Aoki T, Okada N, Wakamatsu T, et al. TBP-interacting protein 120B, which is induced in relation to myogenesis, binds to NOT3. Biochem Biophys Res Commun 2002;296:1097-103.
17. Aoki T, Okada N, Ishida M, et al. TIP120B: a novel TIP120-family protein that is expressed specifically in muscle tissues. Biochem Biophys Res Commun 1999;261:911-16. (Pubitemid 29408156)
18. Maasho K, Masilamani M, Valas R, et al. The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol Immunol 2005;42:1521-30. (Pubitemid 40798939)
19. Lebbink RJ, van den Berg MC, de Ruiter T, et al. The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction. J Immunol 2008;180:1662-9.